Diclofenac is FDA-approved to treat symptoms of three specific types of arthritis in adults: osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. Diclofenac has FDA boxed warnings about ...

Diclofenac can cause side effects that range from mild to serious. Examples of side effects include kidney problems and sleepiness. If diclofenac side effects become difficult to tolerate, talk with ...

This drug has boxed warnings. A boxed warning is the most serious warning from the Food and Drug Administration (FDA). It alerts doctors and patients about drug effects that may be dangerous.

Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) approved to treat osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis in adults. Typical dosages for diclofenac oral tablets ...

Current guidelines recommend that patients at risk for ulcer disease who require treatment for arthritis receive nonsteroidal antiinflammatory drugs (NSAIDs) that are selective for cyclooxygenase-2 or ...

SPOKANE, Wash. — Safety concerns related to the widely used painkiller diclofenac may be tied to a little-studied drug-metabolizing enzyme whose expression can vary as much as 3,000 times from one ...

When you shop through retailer links on our site, we may earn affiliate commissions. 100% of the fees we collect are used to support our nonprofit mission. Learn more. If you suffer from arthritis or ...

A doctor's prescription cleared millions of pharmacy claims through Medicare Part D for a drug the program was never legally ...

Learn everything you need to know about Diclofenac-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

We addressed the question: Does increasing COX-2 selectivity increase cardiac events? And we found the clear answer to this is: No, it doesn't. Presenting the study at the AHA meeting, Dr Christopher ...

Prophylactic topical diclofenac does not reduce clinically significant hand-foot syndrome (HFS) in patients receiving capecitabine-based therapy, a new real-world observational study found. Grade ≥ 2 ...